Determination of Dysregulated miRNA Expression Levels by qRT-PCR after the Application of Usnic Acid to Breast Cancer
- PMID: 31549595
- DOI: 10.2174/1871520619666190923163552
Determination of Dysregulated miRNA Expression Levels by qRT-PCR after the Application of Usnic Acid to Breast Cancer
Abstract
Background and purpose: Breast cancer still remains to be one of the most threatening cancer types in women. Recent studies have allowed scientists to better investigate the potential use of natural compounds in the treatment of breast cancers. Usnic acid is a secondary metabolite extracted from lichen species and has many biological activities. The response of microRNAs regulated by drug molecules may provide useful diagnostic and prognostic biomarkers, as well as potential therapeutics for breast cancers. Although the aberrant expression of microRNAs was observed after drug treatment, the regulatory mechanisms remain partially known. Micro RNAs (miRNAs) play an important role in gene regulation at the post-transcriptional level.
Methods: In this study, we used quantitative Real-Time PCR (qRT-PCR) technology to demonstrate that usnic acid significantly changes the expression profile of miRNAs.
Results: Eleven miRNAs were significantly and differentially expressed in breast cancer cells after treatment with usnic acid. Three miRNAs were up-regulated, while eight were down-regulated in usnic acid treated cells. Target prediction and GO analysis revealed many target genes and their related pathways that are potentially regulated by usnic acid regulated differentially expressed miRNAs. We found that usnic acid treatment caused significant changes in the expression of hsa-miR-5006-5p, hsa-miR-892c-3p, hsa-miR-4430, hsa-miR-5194, hsa-miR-3198, hsa-miR-3171, hsa-miR-933 and hsa-miR-185-3p in breast cancer cells.
Conclusion: Usnic acid response miRNAs might play important regulatory roles in the tumorigenesis and development of breast cancer, and they could serve as prognostic predictors for breast cancer patients.
Keywords: Usnic acid; breast cancer; miRNAs; prognosis; qRT-PCR; secondary metabolite..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Determination of Usnic Acid Responsive miRNAs in Breast Cancer Cell Lines.Anticancer Agents Med Chem. 2019;19(12):1463-1472. doi: 10.2174/1871520618666181112120142. Anticancer Agents Med Chem. 2019. PMID: 30417797
-
Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.BMC Cardiovasc Disord. 2020 Feb 3;20(1):43. doi: 10.1186/s12872-020-01346-y. BMC Cardiovasc Disord. 2020. PMID: 32013934 Free PMC article.
-
Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling.Biochem Biophys Res Commun. 2016 Oct 28;479(4):893-900. doi: 10.1016/j.bbrc.2016.09.087. Epub 2016 Sep 28. Biochem Biophys Res Commun. 2016. PMID: 27693788
-
The importance of hsa-miR-28 in human malignancies.Biomed Pharmacother. 2023 May;161:114453. doi: 10.1016/j.biopha.2023.114453. Epub 2023 Mar 1. Biomed Pharmacother. 2023. PMID: 36868012 Review.
-
Distinct microRNA expression pattern in breast cancer cells following anti-neoplastic treatment: A systematic review and functional analysis of microRNA target genes.Malays J Pathol. 2022 Dec;44(3):367-385. Malays J Pathol. 2022. PMID: 36591707
Cited by
-
Exosomal encapsulation of miR-3198 promotes proliferation and migration of trophoblasts in preeclampsia.J Assist Reprod Genet. 2024 May;41(5):1403-1416. doi: 10.1007/s10815-024-03104-x. Epub 2024 Mar 27. J Assist Reprod Genet. 2024. PMID: 38536597 Free PMC article.
-
The comparison of miRNAs that respond to anti-breast cancer drugs and usnic acid for the treatment of breast cancer.Cytotechnology. 2020 Oct 30;72(6):855-72. doi: 10.1007/s10616-020-00430-7. Online ahead of print. Cytotechnology. 2020. PMID: 33128199 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical